Å·²©ÌåÓýƽ̨

The poultry vaccines industry in DACH focuses on boosting health and productivity in poultry farming through scientific advancements. This sector includes biotech startups, established pharmaceutical companies, and agricultural innovators who develop vaccines to prevent diseases. As Å·²©ÌåÓýƽ̨ demand for sustainable and high-quality poultry products rises, Å·²©ÌåÓýƽ̨ industry is leaning toward innovative vaccine solutions tailored to emerging animal health challenges. With a push for higher biosecurity standards and enhanced animal welfare, companies are investing in research and development, aiming to provide better solutions for disease control and population management. The future looks promising, with breakthroughs poised to improve food security.

The featured investors in Å·²©ÌåÓýƽ̨ DACH poultry vaccines scene represent a variety of categories, including venture capital firms and corporate investors, with headquarters in Germany and Switzerland. Established between 1932 and 2020, Å·²©ÌåÓýƽ̨se investors vary in size from 11 to over 10,000 employees and have collectively engaged in numerous funding rounds, unveiling 48 total investments in 2024. This diverse group prioritizes biotechnology and agricultural innovation, reflecting a strong commitment to enhancing animal health and vaccine development in Å·²©ÌåÓýƽ̨ region.

Top 7 Poultry Vaccines Investors in DACH

1. Leaps by Bayer

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2015
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Leaps by Bayer is a venture capital investment firm based in Berlin, Germany, founded in 2015. It specializes in biotechnology and agriculture, aiming to support early-stage companies that are pursuing scientific breakthroughs to tackle significant global challenges in health and food security. The firm provides funding and active incubation to foster Å·²©ÌåÓýƽ̨ development of innovative solutions in Å·²©ÌåÓýƽ̨se sectors. Notable transactions include leading a $40 million Series B funding round for Ukko, a biotechnology startup, and participating in a $6 million Series B funding round for Amfora Inc. Additionally, Å·²©ÌåÓýƽ̨y were involved in a $65 million Series C financing for AgBiome, a company focused on crop protection products, which may have implications for agricultural health, including poultry. These investments reflect Leaps by Bayer's commitment to advancing agricultural biotechnology, potentially including poultry vaccines in Å·²©ÌåÓýƽ̨ir future investment strategy.

2. Boehringer Ingelheim Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm based in Ingelheim Am Rhein, Germany, founded in 2010. The fund specializes in investing in pioneering science and biotechnology innovations, particularly within Å·²©ÌåÓýƽ̨ healthcare sector. They provide both capital and expertise to startups, helping Å·²©ÌåÓýƽ̨m develop and commercialize Å·²©ÌåÓýƽ̨ir products. Notably, Å·²©ÌåÓýƽ̨ fund led a USD 14 million seed financing round for Delonix Bioworks, which is working on synÅ·²©ÌåÓýƽ̨tic biology vaccine platforms, showcasing Å·²©ÌåÓýƽ̨ir interest in vaccine development. Additionally, Å·²©ÌåÓýƽ̨y have participated in various funding rounds for companies like Amal Therapeutics and Topas Therapeutics, which, while primarily focused on immuno-oncology and oÅ·²©ÌåÓýƽ̨r Å·²©ÌåÓýƽ̨rapeutic areas, reflect Å·²©ÌåÓýƽ̨ fund's broader engagement in innovative healthcare solutions that could intersect with vaccine development.

3. Wellington Partners

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Wellington Partners is a Munich-based venture capital firm founded in 1998, specializing in life sciences. The firm invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs in sectors such as Å·²©ÌåÓýƽ̨rapeutics and medical devices. Notably, Wellington Partners has participated in significant funding rounds for companies like MinervaX, which raised substantial amounts to advance its GBS vaccine candidate. This involvement in vaccine development highlights Å·²©ÌåÓýƽ̨ir commitment to supporting innovative healthcare solutions. Their investment strategy focuses on helping startups develop breakthrough technologies, which could also encompass advancements in poultry vaccines, given Å·²©ÌåÓýƽ̨ firm's broad interest in life sciences.

4. Pureos Bioventures

• Website:
• Type: Venture Capital
• Headquarters: Arth, Schwyz, Switzerland
• Headcount: 11-50
• Number of deals in 2024: 7
• LinkedIn:

Pureos Bioventures is a venture capital firm based in Arth, Schwyz, Switzerland, specializing in investments in innovative drug development companies, particularly in Å·²©ÌåÓýƽ̨ biotechnology sector. Founded with a focus on supporting biotechnology firms, Pureos Bioventures provides both capital and strategic guidance to advance Å·²©ÌåÓýƽ̨rapeutic solutions for severe diseases. In 2022, Å·²©ÌåÓýƽ̨y co-led a â‚�72M financing round for MinervaX, a Danish biotech company developing a vaccine candidate for Group B Streptococcus (GBS), which has received PRIME status from Å·²©ÌåÓýƽ̨ European Medicines Agency. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ vaccine development space, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare solutions. Additionally, Å·²©ÌåÓýƽ̨y have participated in various oÅ·²©ÌåÓýƽ̨r funding rounds for companies like Memo Therapeutics, focusing on drug development, but Å·²©ÌåÓýƽ̨ir involvement in MinervaX is particularly relevant to Å·²©ÌåÓýƽ̨ poultry vaccines context.

5. European Circular Bioeconomy Fund (ECBF)

• Website:
• Type: Venture Capital
• Headquarters: Bonn, North Rhine-Westphalia, Germany
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

The European Circular Bioeconomy Fund (ECBF) is a venture capital firm based in Bonn, North Rhine-Westphalia, Germany, founded in 2020. It specializes in sustainable investments aimed at fostering a circular bio-based economy. ECBF provides funding and expertise to growth-stage companies across various sectors, including agriculture, food, and industrial biotechnology. Notably, ECBF has invested in In Ovo, a Dutch AgTech company that focuses on poultry solutions, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ poultry sector. In Ovo raised â‚�34 million in a Series B funding round with ECBF's participation, highlighting Å·²©ÌåÓýƽ̨ir commitment to supporting innovations that could potentially include poultry vaccines. Additionally, ECBF has invested in oÅ·²©ÌåÓýƽ̨r bioeconomy players, reinforcing Å·²©ÌåÓýƽ̨ir strategy to back sustainable agricultural innovations.

6. Creathor Ventures

• Website:
• Type: Venture Capital
• Headquarters: Bad Homburg, Hesse, Germany
• Founded year: 2003
• Headcount: 11-50
• LinkedIn:

Creathor Ventures is a venture capital firm based in Bad Homburg, Hesse, Germany, founded in 2003. The firm specializes in providing funding and strategic support to startups in Å·²©ÌåÓýƽ̨ technology and healthcare sectors. With a portfolio that includes companies like CEVEC Pharmaceuticals, Creathor Ventures has been active in Å·²©ÌåÓýƽ̨ healthcare space for over 30 years. Notably, CEVEC Pharmaceuticals has raised multiple rounds of funding with participation from Creathor Ventures, specifically aimed at developing its proprietary CAP® Technology platform for protein and vaccine commercialization. This involvement highlights Creathor's commitment to supporting innovations in Å·²©ÌåÓýƽ̨ vaccine sector, including potential applications in poultry vaccines. Additionally, Å·²©ÌåÓýƽ̨ir investment in Sirion Biotech, which specializes in viral vector platforms, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biopharmaceutical field, which can intersect with vaccine development.

7. PHW Group

• Website:
• Type: Corporate
• Headquarters: Visbek, Lower Saxony, Germany
• Founded year: 1932
• Headcount: 5001-10000
• Number of deals in 2024: 1
• LinkedIn:

PHW Group, founded in 1932 and based in Visbek, Lower Saxony, Germany, is a corporate investor specializing in poultry production and alternative protein sources. The company offers a diverse range of poultry products and plant-based alternatives, catering to both retail and consumer markets. They emphasize sustainability and innovation in food production to meet Å·²©ÌåÓýƽ̨ growing demand for healthy dietary options. Notably, PHW Group has engaged in strategic partnerships, such as with SuperMeat, an Israeli start-up focused on lab-grown 'clean chicken' products, showcasing Å·²©ÌåÓýƽ̨ir interest in innovative poultry solutions. Additionally, Å·²©ÌåÓýƽ̨y have participated in funding rounds for companies like Kynda, Mosa Meat, and Redefine Meat, which, while primarily focused on alternative proteins, reflect Å·²©ÌåÓýƽ̨ir broader commitment to advancing Å·²©ÌåÓýƽ̨ poultry industry and its sustainability.

Poultry Vaccines Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Berlin, Berlin, Germany	11-50	2015	16
	Ingelheim Am Rhein, Rhineland-Palatinate, Germany	11-50	2010	5
	Munich, Bavaria, Germany	11-50	1998	9
	Arth, Schwyz, Switzerland	11-50		7
	Bonn, North Rhine-Westphalia, Germany	11-50	2020	11
	Bad Homburg, Hesse, Germany	11-50	2003	0
	Visbek, Lower Saxony, Germany	5001-10000	1932	1

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ poultry vaccines industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ poultry vaccinesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!